Abstract
Objectives : Atrial myxomas are rare benign tumors; causing
obstructive or embolic complications, and even death, depending on their
site and size. Therefore, once diagnosed, it should be surgically
resected emergency. Atrial myxomas are present about 75% in left atrium
(LA) and about 15% in right atrium (RA). Early diagnosis is a challenge
because of nonspecific manifestations, and sometimes is asymptomatic and
discovered accidentally during TTE. Minimally invasive cardiac surgery
(MICS) has benefits include cosmetically, less pain, shorter intensive
care unit (ICU) and hospital stay. Methods: From Jan. 2011 to
Sept. 2020, (20) patients (10 Sternotomy, 10 MI) underwent surgery for
isolated resection of atrial myxoma. We reported outcomes;
cardiopulmonary bypass time (CPB), cross-clamp time, conversion to
median ST, length of stay, complications (stroke, renal failure,
respiratory failure, reoperation, and infection) , pain, patient′s
satisfaction, recurrence and survival. Mean follow-up time was 6 month.Results : There is no significant difference in CPB or
cross-clamp time between groups. No MI cases required conversion to a
median ST. Length of stay is shorter in the MI group by 2.2 days (p =
0.045). There is no difference in morbidity or mortality between groups.Conclusions: A minimally invasive approach for atrial myxoma
resection is safe, feasible, and favored over sternotomy.
Keywords: Myxoma, Median Sternotomy, Minimal Invasive Cardiac
Surgery, mini-thoracotomy, Heart tumor.